Furthermore, the diagnostic effectiveness of YBX1, MED8, and KPNA2 in the NASH cohort was evaluated using ROC analysis, revealing their exceptional performance with area under the curve (AUC) values of 0.839, 0.875, and 0.946, respectively (Fig. 7I). Here, KPNA2 is linked to metabolic dysfunction-associated steatohepatitis.